The Neoangiogenic Transcriptomic Signature Impacts Hepatocellular Carcinoma Prognosis and Can Be Triggered by Transarterial Chemoembolization Treatment.
Article in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Grazia SerinoNational Institute of Gastroenterology "IRCCS Saverio de Bellis", Research Hospital, 70013 Castellana Grotte, Italy.ORCID 0000-0002-2971-0802
Cristian CaporaliRadiology, Azienda Ospedaliero-Universitaria di Modena, University of Modena and Reggio Emilia, 41125 Modena, Italy.
Paolo MagistriHPB Surgery and Liver Transplant Unit, Azienda Ospedaliero-Universitaria di Modena, University of Modena and Reggio Emilia, 41125 Modena, Italy.
Annarita PecchiRadiology, Azienda Ospedaliero-Universitaria di Modena, University of Modena and Reggio Emilia, 41125 Modena, Italy.
Endrit ShahiniNational Institute of Gastroenterology "IRCCS Saverio de Bellis", Research Hospital, 70013 Castellana Grotte, Italy.ORCID 0000-0002-4909-0436
Fabiola MilosaGastroenterology Unit, CHIMOMO Department, University of Modena and Reggio Emilia, 41124 Modena, Italy.ORCID 0000-0002-9869-8819
Lorenza Di MarcoClinical and Experimental Medicine PhD Program, 41125 Modena, Italy.ORCID 0000-0002-3716-7010
Alessandra PivettiGastroenterology Unit, CHIMOMO Department, University of Modena and Reggio Emilia, 41124 Modena, Italy.ORCID 0000-0001-8271-846X
Simone LasagniGastroenterology Unit, CHIMOMO Department, University of Modena and Reggio Emilia, 41124 Modena, Italy.ORCID 0000-0002-8525-0898
Filippo SchepisM.E.C. Dipartimental Unit, University of Modena and Reggio Emilia, 41125 Modena, Italy.
Nicola De MariaGastroenterology Unit, CHIMOMO Department, University of Modena and Reggio Emilia, 41124 Modena, Italy.
Francesco DituriNational Institute of Gastroenterology "IRCCS Saverio de Bellis", Research Hospital, 70013 Castellana Grotte, Italy.
María Luz Martínez-ChantarLiver Disease Laboratory, Centre for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Bizkaia Technology Park, Building 801A, 48160 Derio, Spain.ORCID 0000-0002-6446-9911
Fabrizio Di BenedettoHPB Surgery and Liver Transplant Unit, Azienda Ospedaliero-Universitaria di Modena, University of Modena and Reggio Emilia, 41125 Modena, Italy.
Gianluigi GiannelliNational Institute of Gastroenterology "IRCCS Saverio de Bellis", Research Hospital, 70013 Castellana Grotte, Italy.ORCID 0000-0002-5140-8060
Erica VillaM.E.C. Dipartimental Unit, University of Modena and Reggio Emilia, 41125 Modena, Italy.ORCID 0000-0001-6388-7022
Funding
Italian Association for Cancer Research grant no. IG 2020‑ID. 24858 project to EVItalian Medicines Agency TRS-2018-00001238 to EVMinistero della Salute RF-2016-02364053 to EVMinistero della Salute RF-2016-02364053 to GGMinistero della Salute Ricerca Corrente 2024 to ESMinistero della Salute Ricerca Corrente 2024 to FDMinistero della Salute Ricerca Corrente 2024 to GG
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
The Neoangiogenic Transcriptomic Signature Impacts Hepatocellular Carcinoma Prognosis and Can Be Triggered by Transarterial Chemoembolization Treatment. · full record | OpenQuestion